Dr. Scandling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Palo Alto, CA 94305Phone+1 650-725-9891
Education & Training
- University of RochesterFellowship, Nephrology, 1981 - 1982
- West Virginia UniversityResidency, Internal Medicine, 1978 - 1981
- Virginia Commonwealth University School of MedicineClass of 1978
Certifications & Licensure
- CA State Medical License 1989 - 2026
- NV State Medical License 2019 - 2025
- VA State Medical License 1984 - 2002
- NY State Medical License 1981 - 1997
- WV State Medical License 1979 - 1995
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) Start of enrollment: 2005 Jun 01
- Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs Start of enrollment: 2004 Jul 01
- Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs. Start of enrollment: 2010 Jul 14
Publications & Presentations
PubMed
- 12 citationsTrends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017.Xingxing S Cheng, Jialin Han, Jennifer L Braggs-Gresham, Philip J Held, Stephan Busque
JAMA Network Open. 2022-03-01 - 8 citationsA new approach to kidney wait-list management in the kidney allocation system era: Pilot implementation and evaluation.Xingxing S. Cheng, Stephan Busque, Jenny Lee, Kevin V. Discipulo, Christine Hartley
Clinical Transplantation. 2018-11-01 - 2 citationsRenal juxtaglomerular apparatus hyperplasiaMegan L. Troxell, John D. Scandling, Richard K. Sibley
Nephrology, Dialysis, Transplantation. 2005-10-01
Journal Articles
- Review Macrochimerism and Clinical Transplant ToleranceSamuel Strober, Stephan Busque, Edgar Engleman, Robert Lowsky, John D Scandling, Judith Shizuru, ScienceDirect
Press Mentions
- Stanford Team Prevents Kidney Transplant Rejection Without DrugsApril 24th, 2002
Grant Support
- Cyclosporine &Neoral In Post Renal Allograft RecipientsNational Center For Research Resources1999–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: